As I understand it,QRS's licencing agreement with BTG expires in 2009.Too close for my liking.Also the competitive threat posed by Varian Medical Systems needs to be assessed.(VAR,NYSE)Comments appreciated.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
